Latest News

Experimental antibody shows early promise for treatment of childhood tumor

Tumors shrank or disappeared and disease progression was temporarily halted in 15 children with advanced neuroblastoma enrolled in a safety study of an experimental antibody. Four patients are still alive after more than two-and-a-half years and without additional treatment. Neuroblastoma is a cancer of the sympathetic nervous system. It is the most common cancer diagnosed in the first year of life and accounts for 7 to 10 percent of childhood cancers.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Ten-hut: New discoveries on how military organization affects civilians

  • Dress for success: Research examines male influences on 'looking' middle class

  • Family members of victims pose a growing challenge for capital punishment

  • Despite academic achievement, pay gaps likely continue between the races

  • Life after prison: Ex-offenders' stigma management

  • The ABC's of animal speech: Not so random after all

  • Combined drugs, therapy most effective for severe nonchronic depression

  • White-matter deficits in users of codeine-containing cough syrups

  • Novel pathway for prevention of heart attack, stroke

  • ADHD children make poor decisions due to less differentiated learning processes

  •